DUBLIN, Sept. 5, 2023/PRNewswire/ -- A newly released research report on the? Allergy Immunotherapy Global Market for 2023 forecasts a market growth from $2.34 billionin 2022 to $2.59 billionin 2023, at a CAGR of 10.5%. This follows the recent news as reported by Financial Times, where Nestlé divested its peanut allergy business, Palforzia, to Swiss healthcare group Stallergenes Greer after slower-than-expected adoption rates. Report Overview The report...